Qiagen QGEN
NYSE QGEN
$44.42 -0.59 (-1.31%)
As of: Sep 29, 2026 · 3:59 PM EDT

Qiagen (QGEN) EBITDA Margin (2009 - 2026)

Updated

Qiagen's EBITDA Margin was 34.31% in the quarter ended Jun 30, 2026, up 2.07 percentage points from 32.24% a year earlier and up 6.64 percentage points from the prior quarter.

Analysis

Qiagen (QGEN) EBITDA Margin (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Qiagen's EBITDA Margin was 30.99% through Jun 30, 2026, down 1.69 percentage points year-over-year; for the year ended Dec 31, 2025, it was 31.72%, up 7.42 percentage points from the prior year.

  • EBITDA Margin shows a five-year change of -2.16 percentage points (years ended Dec 2020 to Dec 2025).
  • In earlier years, EBITDA Margin was 24.30% in the year ended Dec 31, 2024 (-8.54 pp), 32.84% in the year ended Dec 31, 2023 (-3.28 pp), 36.12% in the year ended Dec 31, 2022 (-2.84 pp) and 38.96% in the year ended Dec 31, 2021 (+5.08 pp).
  • The figure for the quarter ended Jun 30, 2026 marks the highest quarterly EBITDA Margin since the quarter ended Jun 30, 2022.
  • Compared with a year earlier, EBITDA Margin was higher in four of the last eight quarters, with an average year-over-year change of +7.35 percentage points.
  • The best year-over-year quarter for EBITDA Margin over five years was the quarter ended Jun 30, 2025 (a gain of 66.48 percentage points); the worst was the quarter ended Jun 30, 2024 (a drop of 67.62 percentage points).
  • Per Business Quant data, QGEN's EBITDA Margin in the three quarters before the quarter ended Jun 30, 2026 was 27.67% (quarter ended Mar 31, 2026), 27.73% (quarter ended Dec 31, 2025) and 34.05% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 21.86%
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 41.08%
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 25.55%
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 29.67%
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 28.17%
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 24.62%
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 31.93%
10 Qiagen 9.76 Bn 5.53 Bn 340.39 Mn 34.31%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.31%
Mar 31, 2026 27.67%
Dec 31, 2025 27.73%
Sep 30, 2025 34.05%
Jun 30, 2025 32.24%
Mar 31, 2025 33.04%
Dec 31, 2024 32.17%
Sep 30, 2024 33.34%
Jun 30, 2024 -34.24%
Mar 31, 2024 33.64%
Dec 31, 2023 32.84%
Sep 30, 2023 32.72%
Jun 30, 2023 33.38%
Mar 31, 2023 32.41%
Dec 31, 2022 33.70%
Sep 30, 2022 31.31%
Jun 30, 2022 35.10%
Mar 31, 2022 42.71%
Dec 31, 2021 39.91%
Sep 30, 2021 36.12%
API Access

Qiagen EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=QGEN&period=max&api_key=YOUR_API_KEY